항응고 관리 및 역전

Strategies to prevent blood loss and reduce transfusion in emergency general surgery, WSES-AAST consensus paper. (새로운 창 열기)

Coccolini F, Shander A, Ceresoli M, Moore E, Tian B, Parini D, Sartelli M, Sakakushev B, Doklestich K, Abu-Zidan F, Horer T, Shelat V, Hardcastle T, Bignami E, Kirkpatrick A, Weber D, Kryvoruchko I, Leppaniemi A, Tan E, Kessel B, Isik A, Cremonini C, Forfori F, Ghiadoni L, Chiarugi M, Ball C, Ottolino P, Hecker A, Mariani D, Melai E, Malbrain M, Agostini V, Podda M, Picetti E, Kluger Y, Rizoli S, Litvin A, Maier R, Beka SG, De Simone B, Bala M, Perez AM, Ordonez C, Bodnaruk Z, Cui Y, Calatayud AP, de Angelis N, Amico F, Pikoulis E, Damaskos D, Coimbra R, Chirica M, Biffl WL, Catena F

Source‎: World J Emerg Surg 2024;19(1):26.

Indexed‎: PubMed 39010099

DOI‎: 10.1186/s13017-024-00554-7

https://pubmed.ncbi.nlm.nih.gov/39010099/ (새로운 창 열기)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (새로운 창 열기)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Source‎: Lancet 2015;385(9982):2077-87.

Indexed‎: PubMed 25728933

DOI‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 (새로운 창 열기)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (새로운 창 열기)

Kaatz S, Kouides PA, Garcia DA, Spyropolous AC, Crowther M, Douketis JD, Chan AK, James A, Moll S, Ortel TL, Van Cott EM, Ansell J.

Source‎: Am J Hematol 2012;87 Suppl 1:S141-5.

Indexed‎: PubMed 22473649

DOI‎: 10.1002/ajh.23202

https://www.ncbi.nlm.nih.gov/pubmed/22473649 (새로운 창 열기)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (새로운 창 열기)

Levi M, Eerenberg E, Kamphuisen PW.

Source‎: J Thromb Haemost 2011;9(9):1705-12.

Indexed‎: PubMed 21729240

DOI‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 (새로운 창 열기)

Emergency reversal of warfarin anticoagulation. (새로운 창 열기)

Lin Y, Callum J.

Source‎: CMAJ 2010;182(18):2004.

Indexed‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (새로운 창 열기)

Management of anticoagulation agents in trauma patients. (새로운 창 열기)

McCoy CC, Lawson JH, Shapiro ML.

Source‎: Clin Lab Med 2014;34(3):563-74.

Indexed‎: PubMed 25168942

DOI‎: 10.1016/j.cll.2014.06.013

https://www.ncbi.nlm.nih.gov/pubmed/25168942 (새로운 창 열기)

Idarucizumab for dabigatran reversal - full cohort analysis. (새로운 창 열기)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Source‎: N Engl J Med 2017;377(5):431-41.

Indexed‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (새로운 창 열기)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (새로운 창 열기)

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

Source‎: Anesth Analg 2011;113(4):703-10.

Indexed‎: PubMed 21890888

DOI‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 (새로운 창 열기)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (새로운 창 열기)

Woo CH, Patel N, Conell C, Rao VA, Faigeles BS, Patel MC, Pombra J, Akins PT, Axelrod YK, Ge IY, Sheridan WF, Flint AC.

Source‎: World Neurosurg 2014;81(1):110-5.

Indexed‎: PubMed 23220122

DOI‎: 10.1016/j.wneu.2012.12.002

https://www.ncbi.nlm.nih.gov/pubmed/23220122 (새로운 창 열기)

외상 및 응급의학과

항응고 관리 및 역전

한국어

항응고 관리 및 역전

https://assetsnffrgf-a.akamaihd.net/assets/ct/e8b2bff3b7/images/syn_placeholder_sqr.png

Strategies to prevent blood loss and reduce transfusion in emergency general surgery, WSES-AAST consensus paper. (새로운 창 열기)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (새로운 창 열기)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (새로운 창 열기)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (새로운 창 열기)

Emergency reversal of warfarin anticoagulation. (새로운 창 열기)

Management of anticoagulation agents in trauma patients. (새로운 창 열기)

Idarucizumab for dabigatran reversal - full cohort analysis. (새로운 창 열기)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (새로운 창 열기)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (새로운 창 열기)

병원 교섭 위원회(HLC)

의학 자료집

동영상

항응고 관리 및 역전

언어를 선택하세요

공유